⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22269 | 1.00 | — | — | |
| SCHEMBL6037582 | 1.00 | — | — | |
| SCHEMBL2184624 | 1.00 | — | — | |
| SCHEMBL1355142 | 1.00 | — | — | |
| SCHEMBL19521748 | 1.00 | — | — | |
| SCHEMBL1355800 | 1.00 | — | — | |
| SCHEMBL31416087 | 1.00 | — | — | |
| SCHEMBL2184981 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL25230162 | 0.98 | CYP2D6 (0.56) | — | |
| Hydrochloric Acid SCHEMBL26120219 | 0.98 | CYP2D6 (0.56) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4189 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11390662-B2 | Collagen mimics | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2022-07-19 | — | — | US | claimed |
| CN-114269769-A | Novel peptide compound or pharmaceutically acceptable salt thereof | 韩国视角生物株式会社 | 2022-04-01 | — | — | CN | claimed |
| US-11203622-B2 | MASP isoforms as inhibitors of complement activation | OMEROS CORPORATION (US) | 2021-12-21 | — | — | US | claimed |
| US-10329341-B2 | Collagen mimics | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2019-06-25 | — | — | US | claimed |
| US-20180030115-A1 | COLLAGEN MIMICS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2018-02-01 | — | — | US | claimed |
| US-9758569-B2 | Collagen mimics | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2017-09-12 | — | — | US | claimed |
| EP-3154568-A1 | NON-CANONICAL INSULINS AND THEIR USES | California Institute of Technology (US) | 2017-04-19 | — | — | EP | claimed |
| EP-2766389-B1 | GENE CLUSTER FOR BIOSYNTHESIS OF GRISELIMYCIN AND METHYLGRISELIMYCIN | SANOFI SA (FR) | 2017-03-29 | — | — | EP | claimed |
| US-9422566-B2 | Gene cluster for biosynthesis of griselimycin and methylgriselimycin | SANOFI (FR) | 2016-08-23 | — | — | US | claimed |
| WO-2015191705-A1 | NON-CANONICAL INSULINS AND THEIR USES | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2015-12-17 | — | — | WO | claimed |
| US-5698672-A | ADMINSTERING TO TREAT OSTEOPOROSIS, PAGET'S DISEASE AND HYPERPARATHYROIDISM | ZYMOGENETICS, INC. (US) | 1997-12-16 | — | — | US | claimed |
| US-5690967-A | MIXTURE CONTAINING AMPHOTERIC AGENT | TRISTRATA TECHNOLOGY, INC. (US) | 1997-11-25 | — | — | US | claimed |
| US-5684044-A | MIXED WITH AMPHOTERIC OR PSEUDOAMPHOTERIC AGENT | TRISTRATA, INCORPORATED (US) | 1997-11-04 | — | — | US | claimed |
| US-5658885-A | OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-19 | — | — | US | claimed |
| WO-1996031536-A1 | SYNTHETIC CALCITONIN MIMETICS | ZYMOGENETICS, INC. (US) | 1996-10-10 | — | — | WO | claimed |
| EP-0413528-B1 | Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use | YU RUEY J (US) | 1995-11-15 | — | — | EP | claimed |
| US-5091171-A | Skin disorders | IGI, INC. | 1992-02-25 | — | — | US | claimed |
| EP-0413528-A1 | Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use | Yu, Ruey J., Dr. (US) | 1991-02-20 | — | — | EP | claimed |
| US-4535102-A | CARBOXYLIC MONOMER WITH UNSATURATED ESTER OR OTHER VINYL COMPOUND AND ORGANIC TITANATE AND INITIATOR | TOKUYAMA SODA KABUSHIKI KAISHA (JP) | 1985-08-13 | — | — | US | claimed |
| US-4482725-A | ANGIOTENSIN CONVERTING ENZYME INHIBITOR | E. R. SQUIBB & SONS, INC. (US) | 1984-11-13 | — | — | US | claimed |